Literature DB >> 21944777

Trichostatin a promotes cardiomyocyte differentiation of rat mesenchymal stem cells after 5-azacytidine induction or during coculture with neonatal cardiomyocytes via a mechanism independent of histone deacetylase inhibition.

Ge Yang1, Jie Tian, Chuan Feng, Li-li Zhao, Zhenguo Liu, Jing Zhu.   

Abstract

This study was to investigate the effect of trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, on cardiac differentiation of bone marrow mesenchymal stem cells (MSCs) in vitro. Rat MSCs were isolated and divided into six groups: 1) control; 2) 5-azacytidine treatment (5-aza, 10 μM); 3) treatment with TSA (100, 300, and 500 nM); 4) treatment with 5-aza followed by incubation with TSA; 5) coculture with neonatal cardiomyocytes (CMs); and 6) treatment with TSA then coculture with CMs. HDAC activity was significantly inhibited in TSA-treated cells with the maximal inhibition after 24 h of exposure to TSA at 300 nM. No changes in HDAC activity were observed in control, 5-aza-treated, or coculture groups. Following 7 days of differentiation, the expression of early cardiac transcription factors GATA-4, NKx2.5, MEF2c, and cardiac troponin T (cTnT) was increased by 6-8 times in the cells in 5-aza-treated, coculture, or TSA-treated groups over control as determined using real-time PCR, immunofluorescence staining, and Western blotting. However, the percent cTnT-positive cells were dramatically different with 0.7% for control, 10% for 5-aza-treated, 25% for coculture, and 4% for TSA-treated group (500 nM). TSA treatment of the cells pretreated with 5-aza or cocultured with CMs dramatically increased the expression of GATA-4, NKx2.5, and MEF2c by 35-50 times over control. The cTnT protein expression was also significantly increased by over threefold by TSA treatment (500 nM) in both 5-aza-treated and coculture group over control. The percent cTnT-positive cells in both 5-aza-pre-treated and coculture groups were significantly increased by TSA treatment after 1 week of differentiation by up to 92.6% (from 10.3% to 19.8%) and 23.9% (from 24.5% to 30.2%), respectively. These data suggested that TSA enhanced the cardiac differentiation of MSCs after 5-aza induction or during coculture with CMs through a mechanism beyond the inhibition of HDAC activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21944777     DOI: 10.3727/096368911X593145

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  22 in total

1.  Local renin-angiotensin system regulates hypoxia-induced vascular endothelial growth factor synthesis in mesenchymal stem cells.

Authors:  Yue Fan; Lulu Wang; Chao Liu; Hongyi Zhu; Lu Zhou; Yu Wang; Xiaowei Wu; Qingping Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Histone modifications interact with DNA methylation at the GATA4 promoter during differentiation of mesenchymal stem cells into cardiomyocyte-like cells.

Authors:  Hao Xu; Qin Yi; Chunmei Yang; Yue Wang; Jie Tian; Jing Zhu
Journal:  Cell Prolif       Date:  2016-04-26       Impact factor: 6.831

Review 3.  Multifunctional properties of chicken embryonic prenatal mesenchymal stem cells- pluripotency, plasticity, and tumor suppression.

Authors:  G Bhuvanalakshmi; Frank Arfuso; Arun Dharmarajan; Sudha Warrier
Journal:  Stem Cell Rev Rep       Date:  2014-12       Impact factor: 5.739

4.  The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent Mechanism.

Authors:  Joseph B Moore; John Zhao; Matthew C L Keith; Alok R Amraotkar; Marcin Wysoczynski; Kyung U Hong; Roberto Bolli
Journal:  Stem Cells       Date:  2016-09-01       Impact factor: 6.277

5.  Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy.

Authors:  Joseph B Moore; Xian-Liang Tang; John Zhao; Annalara G Fischer; Wen-Jian Wu; Shizuka Uchida; Anna M Gumpert; Heather Stowers; Marcin Wysoczynski; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2018-11-16       Impact factor: 17.165

6.  Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming.

Authors:  Androniki Kretsovali; Christiana Hadjimichael; Nikolaos Charmpilas
Journal:  Stem Cells Int       Date:  2012-03-08       Impact factor: 5.443

7.  Knockdown of the HDAC1 promotes the directed differentiation of bone mesenchymal stem cells into cardiomyocytes.

Authors:  Dong-feng Lu; Ying Wang; Zi-zhuo Su; Zhao-hua Zeng; Xiao-wen Xing; Zhi-yu He; Chunxiang Zhang
Journal:  PLoS One       Date:  2014-03-31       Impact factor: 3.240

8.  Islet-1 promotes the cardiac-specific differentiation of mesenchymal stem cells through the regulation of histone acetylation.

Authors:  Naijing Yin; Rong Lu; Jianping Lin; Shenshen Zhi; Jie Tian; Jing Zhu
Journal:  Int J Mol Med       Date:  2014-03-06       Impact factor: 4.101

9.  Synthetic epigenetics-towards intelligent control of epigenetic states and cell identity.

Authors:  Tomasz P Jurkowski; Mirunalini Ravichandran; Peter Stepper
Journal:  Clin Epigenetics       Date:  2015-03-04       Impact factor: 6.551

10.  Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes.

Authors:  Christophe M Raynaud; Najeeb Halabi; David A Elliott; Jennifer Pasquier; Andrew G Elefanty; Edouard G Stanley; Arash Rafii
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.